The New York Academy of Medicine Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00124358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

New York Academy of Medicine | Sackler Institute for Nutrition Science at the New York Academy of Sciences

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (1 trial)

Drugs in Other Trials (1)

thiamine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2